Langerhans cell histiocytosis and dermatophytosis.
暂无分享,去创建一个
[1] S. Leikin. Immunobiology of histiocytosis-X. , 1987, Hematology/oncology clinics of North America.
[2] C. Pochedly,et al. Histiocytosis-X: an overview. , 1987, Hematology/oncology clinics of North America.
[3] F. Gonzalez-crussi,et al. Histiocytosis X: A seven-year experience at a children's hospital. , 1985, Journal of the American Academy of Dermatology.
[4] K. Kragballe,et al. Histiocytosis X–an immune deficiency disease? Studies on antibody‐dependent monocyte‐mediated cytotoxicity , 1981, The British journal of dermatology.
[5] M. O'Leary,et al. The immune system and the histiocytosis syndromes. , 1981, The American journal of pediatric hematology/oncology.
[6] P. Lavin,et al. Histiocytosis-X: Demonstration of Abnormal Immunity, T-Cell Histamine H2-Receptor Deficiency, and Successful Treatment with Thymic Extract , 1981 .
[7] A. Ahmed,et al. Trichophytin reactions in children with tinea capitis. , 1978, Archives of dermatology.
[8] E. Stiehm,et al. Combined immunodeficiency presenting as the Letterer-Siwe syndrome. , 1974, The Journal of pediatrics.
[9] M. Rinaldi,et al. Immunologic susceptibility to chronic dermatophytosis. , 1974, Archives of dermatology.
[10] S. Leikin,et al. Immunologic parameters in histiocytosis‐X , 1973 .